[Organo-tissular and cellular-subcellular tolerance of praziquantel used for chemoprophylaxis and preventive treatment of experimental opisthorchiasis].
D000818:Animals; D006224:Cricetinae; D004361:Drug Tolerance; D006321:Heart / Q000187:drug effects; D007668:Kidney / Q000166:cytology / Q000187:drug effects / Q000648:ultrastructure; D008099:Liver / Q000166:cytology / Q000187:drug effects / Q000648:ultrastructure; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects / Q000648:ultrastructure; D008297:Male; D008647:Mesocricetus; D009206:Myocardium / Q000166:cytology / Q000648:ultrastructure; D009889:Opisthorchiasis / Q000517:prevention & control*; D011223:Praziquantel / Q000009:adverse effects / Q000627:therapeutic use*; D013154:Spleen / Q000166:cytology / Q000187:drug effects / Q000648:ultrastructure
D011223:Praziquantel
Izuchenie perenosimosti prazikvantelia na organno-tkanevom i kletochno-subkletochnom uroviiakh pri ego ispol'zovanii dlia khimioprofilaktiki i preventivnogo lecheniia éksperimental'nogo opistorkhoza.